Skip to main content

Steroid Requirements for Suppression of HMG CoA Reductase Activity in Cultured Human Fibroblasts

  • Chapter
Book cover Lipids, Lipoproteins, and Drugs

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 63))

Abstract

The rate of cholesterol synthesis in cultured human fibroblasts is determined by the activity of 3-hydroxy-3-methylglutary1 coenzyme A reductase (HMG CoA reductase) (1–3). The activity of this enzyme in normal fibroblasts becomes suppressed when low density lipoproteins (LDL) bind to specific receptors on the cell surface (4, 5) and deliver cholesterol and cholesteryl esters to the cell (6). High density lipoproteins (HDL), which do not bind to the LDL receptor (4, 5), do not increase the cellular content of cholesterol and cholesteryl esters (6) nor do they suppress HMG CoA reductase activity and cholesterol synthesis (1, 3). Cultured fibroblasts from subjects with the autosomal dominant disorder familial hypercholesterolemia are deficient in the LDL receptor (4, 5, 7). As a result, LDL does not bind to the cells (4, 5, 7), cholesterol is not transferred intracellularly (6), HMG CoA reductase activity is not suppressed, and cholesterol is overproduced (2, 3).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Brown, M. S., Dana, S. E., and Goldstein, J. L. Proc. Nat. Acad. Sci. USA 70: 2162–2166, 1973.

    Article  PubMed  CAS  Google Scholar 

  2. Goldstein, J. L. and Brown, M. S. Proc. Nat. Acad. Sci. USA 70: 2804–2808, 1973.

    Article  PubMed  CAS  Google Scholar 

  3. Brown, M. S., Dana, S. E., and Goldstein, J. L. J. Biol. Chem. 249: 789–796, 1974.

    PubMed  CAS  Google Scholar 

  4. Brown, M. S. and Goldstein, J. L. Proc. Nat. Acad. Sci. USA 71: 788–792, 1974.

    Article  PubMed  CAS  Google Scholar 

  5. Goldstein, J. L. and Brown, M. S. J. Biol. Chem., in press.

    Google Scholar 

  6. Brown, M. S., Dana, S. E., and Goldstein, J. L. Proc. Nat. Acad. Sci. USA, in press, 1974.

    Google Scholar 

  7. Brown, M. S. and Goldstein, J. L. Science 185: 61–63, 1974.

    Article  PubMed  CAS  Google Scholar 

  8. Brown, M. S. and Goldstein, J. L. J. Biol. Chem., in press, 1974.

    Google Scholar 

  9. Kandutsch, A. A. and Chen, H. W. J. Biol. Chem. 248:8408–8417, 1973.

    PubMed  CAS  Google Scholar 

  10. Chicoye, E., Powrie, W. D., and Fennema, O. Lipids 3: 551–556, 1968.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1975 Plenum Press, New York

About this chapter

Cite this chapter

Goldstein, J.L., Faust, J.R., Brunschede, G.Y., Brown, M.S. (1975). Steroid Requirements for Suppression of HMG CoA Reductase Activity in Cultured Human Fibroblasts. In: Kritchevsky, D., Paoletti, R., Holmes, W.L. (eds) Lipids, Lipoproteins, and Drugs. Advances in Experimental Medicine and Biology, vol 63. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3258-9_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-3258-9_5

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-3260-2

  • Online ISBN: 978-1-4684-3258-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics